Biocatalysed synthesis of β-O-glucosides from 9-fluorenon-2-carbohydroxyesters.: Part 3:: IFN-inducing and anti-HSV-2 properties

被引:12
作者
Alcaro, S
Arena, A
Di Bella, R
Neri, S
Ottanà, R
Ortuso, F
Pavone, B
Trincone, A
Vigorita, MG
机构
[1] Univ Messina, Fac Farm, Dipartimento Farmacochim, I-98168 Messina, Italy
[2] Azienda Ospedaliera Univ G Martino, Fac Med & Chirurg, Unita Microbiol, Dipartimento Discipline Chirurg, I-98125 Messina, Italy
[3] Univ Catanzaro Magna Graecia, Dipartimento Sci Farmacobiol, I-88021 Roccelletta Di Borgia, CZ, Italy
[4] CNR, Ist Chim Biomol, I-80072 Arco Felice Napoli, Italy
关键词
tilorone analogues; 9-fluorenon-2-carbohydroxyesters; 9-fluoren-b-O-glycosides; enzymatic transglycosylation; IFN-inducing properties; conformational analysis;
D O I
10.1016/j.bmc.2005.03.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In pursuing research on the antiviral, interferon (IFN)-inducing tilorone congeners, a new series of fluoren-carboxyhydroxyesters has been prepared and biologically explored. These esters have subsequently been used as sugar acceptors in the enzymatic transglycosylation reaction using the 'retaining' P-glycosidase from the archaeon Sulfolobus solfataricus (Ss beta-Gly). Both aglycones (1-6) and corresponding beta-glucosides (beta-glu 1-beta-glu 6) have been screened for cytotoxicity, interferon-stimulating and antiviral properties against HSV-2. It was found that the addition of compounds beta-glu 5, beta-glu 6 and beta-glu 4 to HSV-2 infected U937 cells downregulates viral replication and triggers cells to release IFN-alpha/beta. Taken together, the results showed improved pharmacological profiles as a consequence of glycosylation. A molecular modelling study carried out on this series of compounds completed the structural characterisation of the novel compounds. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3371 / 3378
页数:8
相关论文
共 39 条
[1]   BIS-BASIC-SUBSTITUTED POLYCYCLIC AROMATIC-COMPOUNDS - NEW CLASS OF ANTIVIRAL AGENTS .3. 2,7-BIS(AMINOACYL)FLUORENES AND -FLUORENONES [J].
ALBRECHT, WL ;
FLEMING, RW ;
HORGAN, SW ;
KIHM, JC ;
MAYER, GD .
JOURNAL OF MEDICINAL CHEMISTRY, 1974, 17 (08) :886-889
[2]   9-fluorenon-4-carboxamides:: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation.: Note II [J].
Alcaro, S ;
Arena, A ;
Di Bella, R ;
Neri, S ;
Ottanà, R ;
Ortuso, F ;
Pavone, B ;
Vigorita, MG .
ARKIVOC, 2004, :334-348
[3]   Design and synthesis of DNA-intercalating 9-fluoren-β-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents [J].
Alcaro, S ;
Arena, A ;
Neri, S ;
Ottanà, R ;
Ortuso, F ;
Pavone, B ;
Vigorita, MG .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (07) :1781-1791
[4]   BIS-BASIC-SUBSTITUTED POLYCYCLIC AROMATIC-COMPOUNDS - NEW CLASS OF ANTIVIRAL AGENTS .2. TILORONE AND RELATED BIS-BASIC ETHERS OF FLUORENONE, FLUORENOL, AND FLUORENE [J].
ANDREWS, ER ;
FLEMING, RW ;
GRISAR, JM ;
KIHM, JC ;
WENSTRUP, DL ;
MAYER, GD .
JOURNAL OF MEDICINAL CHEMISTRY, 1974, 17 (08) :882-886
[5]  
Arcamone F., 1981, DOXORUBICIN ANTICANC
[6]  
BONINA L, 1991, J IMMUNOL RES, V3, P24
[7]  
CHABNER B, 1997, GOODMAN GILMAN BASI, V9, P1203
[8]  
Chandra P, 1977, Top Curr Chem, V72, P125
[9]   Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up [J].
Danve-Szatanek, C ;
Aymard, M ;
Thouvenot, D ;
Morfin, F ;
Agius, G ;
Bertin, I ;
Billaudel, S ;
Chanzy, B ;
Coste-Burel, M ;
Finkielsztejn, L ;
Fleury, H ;
Hadou, T ;
Henquell, C ;
Lafeuille, H ;
Lafon, ME ;
Le Faou, A ;
Legrand, MC ;
Maille, L ;
Mengelle, C ;
Morand, P ;
Morinet, F ;
Nicand, E ;
Omar, S ;
Picard, B ;
Pozzetto, B ;
Puel, J ;
Raoult, D ;
Scieux, C ;
Segondy, M ;
Seigneurin, JM ;
Teyssou, R ;
Zandotti, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (01) :242-249
[10]   Doxoform and daunoform: Anthracycline-formaldehyde conjugates toxic to resistant tumor cells [J].
Fenick, DJ ;
Taatjes, DJ ;
Koch, TH .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (16) :2452-2461